Quantbot Technologies’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Quantbot Technologies’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20	Closed	-$2K	–	1710
2019 Q2	$2K	Buy	+20	New	+$2.16K	﹤0.01%	1137
2018 Q2	–	Sell	-711	Closed	-$47K	–	1648
2018 Q1	$47K	Buy	+711	New	+$41.1K	﹤0.01%	985
2017 Q2	–	Sell	-1,741	Closed	-$92K	–	1501
2017 Q1	$92K	Buy	1,741 +154	+10%	+$9.14K	0.01%	808
2016 Q4	$79K	Buy	1,587 +1,179	+289%	+$63.2K	0.01%	750
2016 Q3	$24K	Sell	408 -2,028	-83%	-$117K	﹤0.01%	935
2016 Q2	$124K	Buy	+2,436	New	+$104K	0.01%	662

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Quantbot Technologies's ONCE Position: Q3 2019 in Review

Quantbot Technologies sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 20 shares — an estimated $2K sold.

Quantbot Technologies first reported a position in ONCE in Q2 2016 and held it in 6 quarters. The position peaked at $124K in Q2 2016. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

Quantbot Technologies reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Quantbot Technologies sold 20 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $2K.
Quantbot Technologies first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
Quantbot Technologies's Spark Therapeutics, Inc. Common Stock position peaked at $124K in Q2 2016.
184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Quantbot Technologies's 13F filing for Q3 2019, filed 12 Nov 2019.